Utilization and expenditure on blood glucose test strips in Canada

Canadian Journal of Diabetes

Volumn 34, Issue 1, 2010, Pages 34-40

  Cameron, Chris ^a   Virani, Adil ^b,c   Dean, Heather ^b,d   Evans, Mike ^b,e,f   Dolovich, Lisa ^b,g   Dahl, Marshall ^b,h  

^a CANADIAN AGENCY FOR DRUGS AND TECHNOLOGIES IN HEALTH   (Canada)

^b Canadian Optimal Medication Prescribing and Utilization Service (COMPUS)

^c University of Manitoba ^*

^d UNIVERSITY OF MANITOBA   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Blood glucose test strips; Canada; Cost; Diabetes; Drug utilization; Expenditure; Frequency; Self monitoring of blood glucose

Indexed keywords

EID: 77955737653     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-2671(10)41008-4     Document Type: Article

References (38)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32(suppl 1):i-S201.
2. Bergenstal RM, Gavin JR, Global Consensus Conference on Glucose Monitoring Panel. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am J Med. 2005;118(Suppl 9A):1S-6S.
3. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 2008;31:S12-S54.
4. National Collaborating Centre for Women's and Children's Health and the National Collaborating Centre for Chronic Conditions. Type 1 diabetes: diagnosis and management of type 1 diabetes in children, young people and adults. Clinical guideline 15. London, UK: National Institute for Clinical Excellence; 2004. Available at: http://www.nice.org.uk/nicemedia/pdf/CG015NICEguideline.pdf. Accessed April 20, 2010.
5. National Collaborating Centre for Chronic Conditions. Type 2 diabetes: National clinical guideline for management in primary and secondary care (update). London, UK: Royal College of Physicians; 2008. Available at: http://www.nice.org.uk/nicemedia/pdf/CG66diabetesfullguideline.pdf. Accessed April 20, 2010.
6. Diabetes UK. Care recommendations. London, UK: Diabetes UK; 2008. Available at: http://www.diabetes.org.uk/About_us/Our_Views/Care_recommendations. Accessed April 20, 2010.
7. Harris P, Mann L, Marshall P, et al. Diabetes management in general practice: Guidelines for type 2 diabetes. Canberra: Diabetes Australia; 2008. Available at: http://www.diabetesaustralia.com.au/PageFiles/763/DiabetesinGeneralPractice0809.pdf. Accessed April 20, 2010.
8. Canadian Agency for Drugs and Technologies in Health. Optimal therapy recommendations for the prescribing and use of blood glucose test strips. Ottawa: The Agency; 2009 (Optimal therapy report; vol. 3 no. 6). Available at: http://www.cadth.ca/media/pdf/compus_BGTS_OT_Rec_e.pdf. Accessed April 20, 2010.
9. Bodmer M, Meier C, Krähenbühl S, et al. Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis. Diabetes Care. 2008;31:2086-2091.
10. Canadian Agency for Drugs and Technologies in Health. Systematic review of use of blood glucose test strips for the management of diabetes mellitus. Ottawa, ON: The Agency; 2008 (Optimal therapy report; vol. 3 no. 2). Available at: http://www.cadth.ca/media/pdf/BGTS_SR_Report_of_Clinical_Outcomes.pdf. Accessed April 20, 2010.
11. St. John A, Davis WA, Price CP, et al. The value of self-monitoring of blood glucose: a review of recent evidence. J Diabetes Complications. 2009 Feb 19 (epub).
12. Towfigh A, Romanova M, Weinreb JE, et al. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis. Am J Manag Care. 2008; 14:468-475.
13. Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care. 2005;28: 1510-1517.
14. Utilization of oral antiglycemics in Canada. Ottawa, ON: Brogan, Inc.; 2008.
15. Canadian Agency for Drugs and Technologies in Health. Current utilization of blood glucose test strips in Canada. Ottawa, ON: The Agency; 2009 (Optimal therapy report; vol. 3, no. 4). Available at: http://www.cadth.ca/media/pdf/compus_CU_Report-BGTS.pdf. Accessed April 20, 2010.
16. Davidson MB. Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin. A waste of money. Diabetes Care. 2005;28:1531-1533.
17. Farmer A, Neil A. In response to 'variations in glucose selfmonitoring during oral hypoglycaemic therapy in primary care'. Diabet Med. 2005;22:511-512.
18. Coyle D, Graham JD. The role of economics in Canadian clinical practice guidelines of drug therapy. Dis Manage Health Outcomes. 2009;11:45-48.
19. Johnson JA, Edwards AL. Evidence and advocacy: are all things considered? CMAJ. 2006;174:1856.
20. Scottish Intercollegiate Guidelines Network (SIGN). Management of diabetes: a draft for consultation. Edinburgh, Scotland: SIGN; In press. 2009.
21. Swedish Council on Technology Assessment in Health Care. [National guidelines for diabetes care, decision support for the priorities 2009 - preliminary version. Recommendation]. Stockholm: SBU; 2009. Available at: http://www.socialstyrelsen.se/publikationer2009/2009-126-135. Accessed April 20, 2010.
22. Farmer A, Wade A, French D, et al. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial. Health Technol Assess. 2009;13:iii-iv, ix-xi, 1-50.
23. Brogan Inc. Ottawa, ON: Brogan Inc.; 2008. Available at: http://www.broganinc.com/index.html. Accessed April 20, 2010.
24. Canadian Diabetes Association. Financial coverage charts for diabetes supplies and medication: Alberta. Toronto, ON: Canadian Diabetes Association; 2009. Available at: http://www.diabetes.ca/documents/get-involved/AB.govt-approved_.jan09_.pdf. Accessed April 20, 2010.
25. Canadian Diabetes Association. Financial coverage charts for diabetes supplies and medication: New Brunswick. Toronto, ON: Canadian Diabetes Association; 2008. Available at: http://www.diabetes.ca/files/diabetesreport2005/NBO5final.pdf. Accessed April 20, 2010.
26. Canadian Diabetes Association. Financial coverage charts for diabetes supplies and medication: Prince Edward Island. Toronto, ON: Canadian Diabetes Association; 2008. Available at: http://www.diabetes.ca/files/diabetesreport2005/PE05final.pdf. Accessed April 20, 2010.
27. Canadian Diabetes Association. Financial coverage charts for diabetes supplies and medication: Northwest Territories. Toronto, ON: Canadian Diabetes Association; 2008. Available at: http://www.diabetes.ca/files/diabetesreport2005/NT05final.pdf. Accessed April 20, 2010.
28. Canadian Diabetes Association. Financial coverage charts for diabetes supplies and medication: Yukon Territory. Toronto, ON: Canadian Diabetes Association; 2008. Available at: http://www.diabetes.ca/files/diabetesreport2005/YK05final.pdf Accessed April 20, 2010.
29. Canadian Diabetes Association. Financial coverage charts for diabetes supplies and medication: Nunavut. Toronto, ON: Canadian Diabetes Association; 2006. Available at: http://www.diabetes.ca/files/diabetesreport2005/NU05final.pdf. Accessed April 20, 2010.
30. Johnson JA, Pohar SL, Secnik K, et al. Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001. BMC Health Serv Res. 2006;6:159.
31. Sanyal C, Graham S, Cook C, et al. The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiars of the Seniors' Pharmacare Program in Nova Scotia Canada. BMC Health Serv Res. 2008;8:111.
32. Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes Registry. Am J Med. 2001;111:1-9.
33. Health Canada. Diabetes in Canada. 2nd ed. Ottawa, ON: Health Canada; 2002. Available at: http://www.phac-aspc.gc.ca/publicat/dic-dac2/pdf/dic-dac2_en.pdf. Accessed April 20, 2010.
34. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
35. Cameron C, Coyle D, Ur E, et al. Cost-effectiveness of selfmonitoring of blood glucose in patients with type 2 diabetes mellitus managed with insulin. CMAJ. 2010;182:28-34.
36. Ministry of Health and Long-Term Care. 2005/06 report card for the Ontario drug benefit program. Toronto, ON: The Ministry of Health and Long-Term Care; 2006. Available at: http://www.health.gov.on.ca/english/public/pub/ministry_reports/odb_report05/drug_rep.html. Accessed April 20, 2010.
37. Ministry of Health and Long-Term Care. 2004/05 report card for the Ontario drug benefit program. Toronto, ON: The Ministry of Health and Long-Term Care; 2005. Available: http://www.health.gov.on.ca/english/public/pub/ministry_reports/odb_report04/drug_rep.html. Accessed April 20, 2010.
38. Ministry of Health and Long-Term Care. 2003/04 report card for the Ontario drug benefit program. Toronto, ON: The Ministry of Health and Long-Term Care; 2004. Available at: http://www.health.gov.on.ca/english/public/pub/ministry_reports/odb_report03/drug_rep.html. Accessed April 20, 2010